sulfamethoxazole has been researched along with tolbutamide in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (37.93) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 8 (27.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Angelini, G; Meneghini, CL | 1 |
| Rahal, JJ; Simberkoff, MS | 1 |
| Amla, V; Kohli, K; Sharma, JD | 1 |
| Hughes, WT; Smith-McCain, BL | 1 |
| Garg, SK; Ghosh, SS; Mathur, VS | 1 |
| Miners, JO; Wing, LM | 1 |
| Hatao, K; Kaku, K; Kaneko, T; Matsuda, M; Tsuchiya, M | 1 |
| Hasselblatt, A; Poser, W; Schwabe, U | 1 |
| Hossie, RD; Mattok, GL; McGilveray, IJ | 1 |
| Funk, KF | 1 |
| Hanano, M; Iga, T; Sawada, Y; Sugita, O; Sugiyama, Y | 1 |
| Günter, S; Kunkel, A; Wätzig, H | 2 |
| Back, DJ; Gill, HJ; Kitteringham, NR; Park, BK; Pirmohamed, M; Tjia, JF | 1 |
| Kunkel, A; Wätzig, H | 2 |
| Miller, JL; Trepanier, LA | 1 |
29 other study(ies) available for sulfamethoxazole and tolbutamide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Group sensitization by photosensitizing drugs].
Topics: Carbutamide; Chlorpropamide; Drug Interactions; Photosensitivity Disorders; Promethazine; Structure-Activity Relationship; Sulfamethoxazole; Sulfonamides; Tartrazine; Tolbutamide | 1978 |
Urinary frequency in a diabetic.
Topics: Adult; Diabetes Complications; Drug Interactions; Female; Humans; Sulfamethoxazole; Tolbutamide; Trimethoprim; Urinary Tract Infections | 1977 |
Modification of hypoglycaemic effect of tolbutamide by co-trimoxazole.
Topics: Animals; Blood Glucose; Drug Combinations; Drug Interactions; Female; Male; Rabbits; Sulfamethoxazole; Tolbutamide; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Effects of sulfonylurea compounds on Pneumocystis carinii.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Carbutamide; Chemical Phenomena; Chemistry; Drug Combinations; Immune Tolerance; Pneumonia, Pneumocystis; Rats; Sulfamethoxazole; Tolbutamide; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Effect of tolbutamide treatment on the pharmacokinetics of intravenously administered sulphamethoxazole in rabbits.
Topics: Animals; Arylamine N-Acetyltransferase; Kinetics; Male; Protein Binding; Rabbits; Sulfamethoxazole; Tolbutamide | 1987 |
Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
Topics: Adult; Drug Combinations; Drug Interactions; Humans; Male; Metabolic Clearance Rate; Protein Binding; Sulfamethoxazole; Tolbutamide; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Sulfonylurea stimulates liver fructose-2,6-bisphosphate formation in proportion to its hypoglycemic action.
Topics: Acetohexamide; Animals; Buformin; Chlorpropamide; Fructosediphosphates; Gliclazide; Gluconeogenesis; Glyburide; Glycolysis; Hexosediphosphates; In Vitro Techniques; Liver; Male; Rats; Rats, Inbred Strains; Stimulation, Chemical; Sulfamethoxazole; Sulfonylurea Compounds; Tolbutamide | 1985 |
[The blood sugar lowering effect of sulfafurazole and sulfamethoxazole in the rat].
Topics: Animals; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Hepatectomy; Hypoglycemia; Male; Oxazoles; Rats; Sulfamethoxazole; Sulfisoxazole; Tolbutamide | 1969 |
Technical problems of the USP-NF dissolution test.
Topics: Formularies as Topic; Hydrochloric Acid; Hydrogen-Ion Concentration; Methods; Pharmacopoeias as Topic; Phosphates; Solubility; Sulfamethoxazole; Sulfisoxazole; Tablets; Time Factors; Tolbutamide; Tromethamine | 1972 |
[Effect of protein binding on the pharmacokinetics of sulfanilamides in rats].
Topics: Animals; Drug Antagonism; Drug Interactions; Glomerular Filtration Rate; Protein Binding; Rats; Rats, Inbred Strains; Sulfamerazine; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfanilamides; Sulfisomidine; Tolbutamide | 1971 |
Prediction of drug-drug interaction from in vitro plasma protein binding and metabolism. A study of tolbutamide-sulfonamide interaction in rats.
Topics: Animals; Blood Proteins; Drug Interactions; Half-Life; Male; Mathematics; Metabolic Clearance Rate; Rats; Rats, Inbred Strains; Sulfadimethoxine; Sulfamethoxazole; Sulfaphenazole; Sulfonamides; Tolbutamide | 1981 |
Quantitation of acetaminophen and salicylic acid in plasma using capillary electrophoresis without sample pretreatment. Improvement of precision.
Topics: Acetaminophen; Borates; Buffers; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Reproducibility of Results; Salicylates; Salicylic Acid; Sodium Dodecyl Sulfate; Sulfamethoxazole; Tolbutamide | 1997 |
Determination of pharmaceuticals in plasma by capillary electrophoresis without sample pretreatment reproducibility, limit of quantitation and limit of detection.
Topics: Acetaminophen; Buffers; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Reproducibility of Results; Salicylates; Salicylic Acid; Sodium Dodecyl Sulfate; Sulfamethoxazole; Tolbutamide; Trimethoprim | 1997 |
The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation.
Topics: Aryl Hydrocarbon Hydroxylases; Base Sequence; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; DNA Primers; Humans; Hydroxylation; Kinetics; Microsomes, Liver; Mutation; Polymorphism, Genetic; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sulfamethoxazole; Tolbutamide | 1999 |
Pharmacokinetic investigations with direct injection of plasma samples: possible savings using capillary electrophoresis (CE).
Topics: Acetaminophen; Blood Proteins; Drug Monitoring; Electrophoresis, Capillary; Humans; Reproducibility of Results; Salicylic Acid; Sulfamethoxazole; Theophylline; Tolbutamide; Trimethoprim | 1999 |
Micellar electrokinetic capillary chromatography as a powerful tool for pharmacological investigations without sample pretreatment: a precise technique providing cost advantages and limits of detection to the low nanomolar range.
Topics: Acetaminophen; Chromatography, Micellar Electrokinetic Capillary; Costs and Cost Analysis; Humans; Reproducibility of Results; Salicylic Acid; Sulfamethoxazole; Theophylline; Time Factors; Tolbutamide; Trimethoprim | 1999 |
NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes.
Topics: Adult; Animals; Anti-Infective Agents; Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dextromethorphan; Dogs; Erythromycin; Female; Humans; Inactivation, Metabolic; Kinetics; Male; Microsomes, Liver; Middle Aged; NAD; Oxidation-Reduction; Oxidoreductases; Oxidoreductases, N-Demethylating; Protein Synthesis Inhibitors; Species Specificity; Sulfamethoxazole; Tolbutamide | 2000 |